[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MXPA04004365A - Novedosas sales mandelato de derivados de tetrahidrofurano tetraciclico sustituido. - Google Patents

Novedosas sales mandelato de derivados de tetrahidrofurano tetraciclico sustituido.

Info

Publication number
MXPA04004365A
MXPA04004365A MXPA04004365A MXPA04004365A MXPA04004365A MX PA04004365 A MXPA04004365 A MX PA04004365A MX PA04004365 A MXPA04004365 A MX PA04004365A MX PA04004365 A MXPA04004365 A MX PA04004365A MX PA04004365 A MXPA04004365 A MX PA04004365A
Authority
MX
Mexico
Prior art keywords
mandelate
mandelate salts
novel
salts according
salts
Prior art date
Application number
MXPA04004365A
Other languages
English (en)
Inventor
Johan Erwin Edmond Weerts
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MXPA04004365A publication Critical patent/MXPA04004365A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

El objetivo de la presente invencion es presentar una novedosa sal mandelato de un derivado de tetrahidrofurano tetraciclico sustituido de acuerdo con la formula (I) ver formula (I) las formas de N-oxido y las formas estereoquimicamente isomericas de los mismos, en los cuales cada uno de R1 y R2 es independientemente hidrogeno o alquilo C1-C6 y cada uno de R3 y R4 es independientemente hidrogeno o halogeno; en las definiciones que anteceden, alquilo C1-C6 define radicales hidrocarburo de cadena recta o ramificada con 1 a 6 atomos de carbono tales como, por ejemplo, metilo, etilo, propilo, butilo, 1-metilpropilo, 1,1-dimetiletilo, pentilo y hexilo; la novedosa sal mandelato no es fotosensible y es mucho mas estable que las sales de la tecnica anterior a temperatura ambiente, a temperatura incrementada y a humedades relativas elevadas, asi como en medios acuosos; tambien se describen composiciones farmaceuticas que comprenden las sales mandelato de acuerdo con la presente invencion, las sales madelato de acuerdo con la presente invencion para usar como medicamento, un procedimiento para la preparacion de las sales mandelato de acuerdo con la presente invencion y el uso de las sales mandelato y composiciones farmaceuticas que comprende sales mandelato de acuerdo con la invencion para el tratamiento o la prevencion de trastornos del SNC, trastornos cardiovasculares y trastornos gastrointestinales.
MXPA04004365A 2001-11-09 2002-11-08 Novedosas sales mandelato de derivados de tetrahidrofurano tetraciclico sustituido. MXPA04004365A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204465 2001-11-09
PCT/EP2002/011136 WO2003040122A1 (en) 2001-11-09 2002-11-08 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives

Publications (1)

Publication Number Publication Date
MXPA04004365A true MXPA04004365A (es) 2004-08-11

Family

ID=8181272

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04004365A MXPA04004365A (es) 2001-11-09 2002-11-08 Novedosas sales mandelato de derivados de tetrahidrofurano tetraciclico sustituido.

Country Status (25)

Country Link
US (1) US7317115B2 (es)
EP (1) EP1446397B1 (es)
JP (1) JP2005508988A (es)
KR (1) KR100962325B1 (es)
CN (1) CN1582282B (es)
AR (1) AR037285A1 (es)
AT (1) ATE299138T1 (es)
AU (1) AU2002349327B2 (es)
BR (1) BR0212770A (es)
CA (1) CA2465043C (es)
DE (1) DE60204982T2 (es)
EA (1) EA006980B1 (es)
ES (1) ES2244818T3 (es)
HR (1) HRP20040395A2 (es)
HU (1) HUP0402224A3 (es)
IL (2) IL161866A0 (es)
MX (1) MXPA04004365A (es)
MY (1) MY128237A (es)
NO (1) NO328548B1 (es)
NZ (1) NZ531739A (es)
PL (1) PL368456A1 (es)
TW (1) TW200407117A (es)
UA (1) UA79248C2 (es)
WO (1) WO2003040122A1 (es)
ZA (1) ZA200403454B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0402152A3 (en) * 2001-12-07 2007-03-28 Janssen Pharmaceutica Nv Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties
RU2401257C2 (ru) 2004-12-07 2010-10-10 Янссен Фармацевтика Н.В. Новые замещенные тетрациклические производные тетрагидрофурана, пирролидина и тетрагидротиофена
EA013595B1 (ru) 2005-01-27 2010-06-30 Янссен Фармацевтика Н.В. Гетероциклические, тетрациклические производные гидрофурана в качестве ингибиторов 5htв терапии расстройств цнс
DE602006012832D1 (de) 2005-06-17 2010-04-22 Janssen Pharmaceutica Nv Neue tetracyclische tetrahydrofuran-derivate mit cyclischer aminseitenkette
US8507040B2 (en) 2008-05-08 2013-08-13 Air Products And Chemicals, Inc. Binary and ternary metal chalcogenide materials and method of making and using same
US8765223B2 (en) * 2008-05-08 2014-07-01 Air Products And Chemicals, Inc. Binary and ternary metal chalcogenide materials and method of making and using same
US8962675B1 (en) * 2013-09-12 2015-02-24 Abbvie Inc. Atrasentan mandelate salts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3644462A1 (de) 1986-12-24 1988-07-07 Basf Ag Verfahren zur herstellung von 5h-dibenzo(a,d)cyclohepten-5-onen
JP2656720B2 (ja) * 1992-12-09 1997-09-24 武田薬品工業株式会社 光学活性アミノクマラン誘導体
ATE201680T1 (de) * 1994-03-16 2001-06-15 Cenes Ltd 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze
PL190960B1 (pl) 1996-04-12 2006-02-28 Janssen Pharmaceutica Nv Tetracykliczna pochodna tetrahydrofuranu, kompozycja farmaceutyczna i sposób wytwarzania tetracyklicznej pochodnej tetrahydrofuranu
SK284145B6 (sk) 1996-05-20 2004-10-05 Janssen Pharmaceutica N. V. Antifungálne prostriedky so zlepšenou biologickou dostupnosťou
UA52778C2 (uk) * 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
US6281247B1 (en) * 1998-03-03 2001-08-28 Novo Nordisk A/S Salt forms of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphthyl)ethyl)amide
HUP9904624A2 (hu) * 1999-12-17 2002-01-28 Sanofi-Synthelabo Szacharinszármazékok, eljárás előállításukra, az ezeket tartalmazó gyógyszerkészítmények és intermedierjeik
EP1186303A3 (en) * 2000-09-06 2003-12-10 Pfizer Products Inc. Pharmaceutical combinations, for the treatment of stroke and traumatic brain injury, containing a neutrophil inhibiting factor and an selective NMDA-NR2B receptor antagonist

Also Published As

Publication number Publication date
KR100962325B1 (ko) 2010-06-11
EP1446397A1 (en) 2004-08-18
DE60204982D1 (de) 2005-08-11
DE60204982T2 (de) 2006-04-27
JP2005508988A (ja) 2005-04-07
WO2003040122A1 (en) 2003-05-15
US20050085533A1 (en) 2005-04-21
ATE299138T1 (de) 2005-07-15
IL161866A0 (en) 2005-11-20
BR0212770A (pt) 2004-10-13
CN1582282B (zh) 2012-06-06
CN1582282A (zh) 2005-02-16
CA2465043A1 (en) 2003-05-15
HUP0402224A2 (hu) 2005-02-28
NO20041848L (no) 2004-05-05
UA79248C2 (en) 2007-06-11
AR037285A1 (es) 2004-11-03
NZ531739A (en) 2005-02-25
KR20050044310A (ko) 2005-05-12
EA006980B1 (ru) 2006-06-30
TW200407117A (en) 2004-05-16
HRP20040395A2 (en) 2005-04-30
ES2244818T3 (es) 2005-12-16
US7317115B2 (en) 2008-01-08
HUP0402224A3 (en) 2007-05-29
NO328548B1 (no) 2010-03-15
IL161866A (en) 2010-04-29
MY128237A (en) 2007-01-31
ZA200403454B (en) 2005-08-31
CA2465043C (en) 2011-02-15
PL368456A1 (en) 2005-03-21
AU2002349327B2 (en) 2008-10-23
EP1446397B1 (en) 2005-07-06
EA200400656A1 (ru) 2004-10-28

Similar Documents

Publication Publication Date Title
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
MXPA03006248A (es) Derivados de acido fumarico como inhibidores de nf-kappab.
HUT62893A (en) Process for producing substituted pyrimidine derivatives and pharmaceutical compositions comprising such compounds as active ingredient
MXPA04000814A (es) Derivados de 2h-piridazina-3-ona novedosos, composiciones farmaceuticas que contienen a los mismos y un procedimiento para la preparacion del ingrediente activo.
NZ240050A (en) Substituted piperazine derivatives; pharmaceutical compositions and preparatory processes
EP1348706A4 (en) SUBSTITUTED THIAZOLE DERIVATIVES CARRYING 3-PYRIDYL GROUPS, PROCESS FOR THEIR PRODUCTION AND USE THEREOF
ATE457981T1 (de) 3-amido-1,2-benzisoxazolderivate, herstellungsverfahren und deren verwendung
MXPA04004365A (es) Novedosas sales mandelato de derivados de tetrahidrofurano tetraciclico sustituido.
MX2024003727A (es) Derivados de morfolinas sustituidas y usos de estos.
MX9803730A (es) Nuevo proceso de preparacion de derivados de fenilimidazolidina.
AU3608195A (en) N-substituted piperidinyl bicyclic benzoate derivatives
TW360650B (en) Pyridin-2-ylmethyloxy-pyridin-5-ylcarbamoyl-indoline derivatives, a process for the preparation thereof, and a pharmaceutical composition comprising them
YU76500A (sh) Hemijska sinzeza morfolinskih derivata
SG146627A1 (en) Imidazole derivatives
AP1396A (en) 1-Trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives.
HUP9601331A2 (hu) Piperazin- illetve homopiperazinszármazékok, eljárás előállításukra, és ilyen hatóanyagot tartalmazó gyógyászati készítmények
EP0703232A3 (en) 2,3-dihydro-1H-isoindole derivatives, process for their preparation and their use as serotonin re-assimilation inhibitors
NZ538160A (en) Process for the preparation of phenylalanine enamide derivatives
MXPA04002784A (es) Sales farmaceuticamente aceptables de 20(s)-camptotecinas.
DE602005012826D1 (de) Neue mao-b-hemmer
WO2002040465A3 (en) Aryloxy piperidinyl indoles for treating depression
MY104630A (en) 4(1h) ouinoline derivatives
YU79401A (sh) Derivati 1-trifluorometil-4-hidroksi-7-piperidinil- aminometilhromana
TH60797A (th) เกลือแมนเดเลตชนิดใหม่ของอนุพันธ์เททราไซคลิคเททราไฮโดรฟิวแรนที่มีหมู่แทนที่
NO20026201D0 (no) Fremgangsmåte for fremstilling av 4-brom-anilin-derivater

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights